OBJECTIVES: Recent evidence has emphasized multifunctional therapeutic effects of statins on renal protection after cardiac surgeries. We aimed to assess the effects of preoperative administration of statins on lowering the incidence of postoperative acute kidney injury in patients undergoing cardiac surgeries.
INTRODUCTION
Acute kidney injury is a life-threatening consequence of major surgeries including cardiac surgery afflicting 1-30% of patients. This condition ultimately leads to dialysis in 1-5% of affected patients [1] . Hence, the postoperative occurrence of this event may increase the risk for mortality and morbidity as well as prolonged hospital stay creating higher financial burden. Various causes have been identified that could lead to acute kidney injury after cardiac surgeries. They include embolism, perfusion abnormalities in the superficial kidney cortex during the cardiopulmonary bypass and renal ischaemia due to renal artery hypoperfusion caused by surgery-related inflammatory response [2, 3] . In this regard, therapeutic agents that can protect the kidneys against these pathologically disturbing events have recently received special attention.
3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors or statins are now widely used for patients who suffer from cardiovascular ischaemic disorders and also following cardiac surgeries. These drugs have a multiple role in protecting injured cardiovascular systems by decreasing cytokines release [4] . They also can be effective in reperfusion of injured organs [5] . It has been shown that administering statins in patients with cardiac surgery can effectively reduce circulatory C-reactive protein, tumour necrosis factoralpha and some cytokines including interleukins 1, 6 and 8 [6, 7] . In total, some recent evidence has emphasized the multifunctional therapeutic effects of statins on pathophysiological pathways involving endothelial dysfunction due to ischaemia reperfusion [8] . In this context, it has been observed that the beneficial effects of these drugs might be dose-dependent, so taking statins at high doses can lead to lower incidence of acute kidney injury [9] . However, few studies have been published on dose-dependent effects of statins on preventing postoperative kidney injuries. We aimed to assess the effects of preoperative administration of statins on lowering the incidence of postoperative acute kidney injury in patients undergoing various types of cardiac surgeries.
PATIENTS AND METHODS

Study population
In a large retrospective study, the preoperative, intraoperative and postoperative data of 1064 consecutive patients who underwent different cardiovascular surgeries including coronary artery bypass surgery, valvular surgery or both referred to Ordibehesht and Central hospitals in Shiraz, southern Iran, from 2011 to June 2014 were reviewed. The baseline data (including demographic characteristics, medical history, history of cardiac interventions, echocardiographic parameters of systolic function and valvular states), oral medications, intraoperative data (including type of surgery, the use of cardiopulmonary bypass and the number of arteries or veins used as grafts) and also postoperative data (including surgery-related complications) were collected from recorded files of both inpatients and outpatients and structured as a computerized database. A detailed list of medications such as preoperative or postoperative statins use by the patients was also provided. All types of statins used by the patients before the operations were equalized to the equivalent dose of simvastatin, then according to the administration of the equivalent dose of simvastatin preoperatively, the patients were categorized into one of the three groups of no statin (n = 620), low-dose statin (<40 mg simvastatin, n = 262) or high-dose statin (>40 mg simvastatin, n = 182).
Study end-point
This study attempted to assess the development of acute kidney injury first after cardiac surgeries defined as an increase in serum creatinine level more than 0.3 mg/dl or greater than 50% of the baseline within 48 h after surgery or need for haemodialysis [10] . The second end-point was to compare the incidence of acute kidney injury occurring after receiving different dosages of statins. The study also assessed the early outcome of cardiac surgeries including 30-day mortality and morbidity. All the patients were operated on by a single surgeon in both hospitals to minimize the operator-related variations.
Statistical analysis
Results were presented as mean ± standard deviation for quantitative variables, and were summarized by absolute frequencies and percentages for categorical variables. Continuous variables were compared using t-tests and one-way ANOVA tests or nonparametric Mann-Whitney U-test or Kruskal-Wallis tests whenever the data did not appear to have normal distribution or when the assumption of equal variances was violated across the groups. Categorical variables were, on the other hand, compared using χ 2 test or Fisher's exact test when more than 20% of cells with expected count of less than 5 were observed. The Pearson's correlation test was applied to examine the association between the study measures. The multivariate logistic regression analysis was used for assessing the study outcomes after employing different dosages of statin as follows: firstly, the baseline variables as probable confounders with a P-value <0.20 in univariate analyses were taken in a multivariate logistic regression model to assess the difference between the groups received high-dose and low-dose statins with the presence of these confounders. For the statistical analysis, the SPSS software version 20.0 for windows (SPSS, Inc., Chicago, IL, USA) was used. P-values of 0.05 or less were considered statistically significant.
RESULTS
The three groups were similar in sex, mean age, history of cardiac intervention, history of smoking, diabetes mellitus and its related treatment regimens, chronic lung diseases including chronic obstructive pulmonary disease (COPD), emphysema and asthma, as well as in New York Heart Association (NYHA) functional class and mean left ventricular ejection fraction (Table 1) . However, those who received high-dose statin experienced less recent myocardial infarction (MI) than the other groups. Also, the patients who received statin had a higher angina Canadian cardiovascular surgery (CCS) class.
Regarding preoperative oral medications, those patients who received high-dose statin received more beta-blockers and angiotensin converting enzyme (ACE) inhibitors concomitantly, and less digoxin. Intraoperatively, on-pump surgery was scheduled for 91.6, 87.8 and 90.1% of the patients not taking statin, receiving low-dose statin and receiving high-dose statin, respectively (P = 0.209). There was also no difference across the three groups that received no statin, low-dose statin and high-dose statin in terms of mean intubation time (768.39 ± 457. 15 With respect to the occurrence of postoperative acute kidney injury, no difference was found in postoperative incidence of acute kidney injury between the groups not taking statins (11.1%), the group receiving low-dose statin (9.9%) and the group receiving high-dose statin (11.5%) (P = 0.887). Regarding changes in serum creatinine level postoperatively, in the former group, serum creatinine reduced in 36.8%, remained unchanged in 22.6% and increased in 40.6% of the patients. In the group receiving lowdose statin, serum creatinine level reduced in 41.6%, remained unchanged in 21.4% and elevated in 37.0% of the patients. Also, in the group receiving high-dose statin, serum creatinine reduced in 34.1%, remained unchanged in 15.9% and increased in 50.0% of the patients. No differences were found in mean levels of three renal functional indices including serum creatinine, serum blood urea nitrogen (BUN) and also excretory glumelar filteration rate (eGFR) across the three groups before and after cardiac surgery (Table 2) . However, in all the study groups, both serum creatinine and BUN levels were significantly elevated following surgery. Regarding postoperative changes in eGFR, a significant decrease in eGFR was shown in those patients who did not take statins, whereas the patients in the other two groups experienced no change in this parameter (Table 2) .
To determine the main predictors of postoperative acute kidney injury, the multivariate logistic regression analysis showed that advanced age [odds ratio (OR) = 1.043, P < 0.001], recent myocardial infarction within 90 days of surgery (OR = 1.935, P = 0.002) and longer intubation time (OR = 1.001, P = 0.001) could predict occurrence of kidney injury after cardiac surgery. In this context, the preoperative use of ACE inhibitor could effectively prevent occurrence of this postoperative event (OR = 0.552, P = 0.008) ( Table 3) .
In multivariable regression modelling (Table 4) , after adjusting for propensity score only, statin treatment, at low or high doses was not associated with postoperative acute kidney injury (OR = 1.010, P = 0.971 for low dose and OR = 1.108, P = 0.745 for high dose versus no statin). After further adjustment for propensity score, statin treatment with the different dosages was not associated with acute kidney injury (OR = 0.869, P = 0.633 for low dose and OR = 1.051, P = 0.885 for high dose versus no statin).
DISCUSSION
Although some clinical trials have addressed positive effects in patients using statins undergoing various cardiac operations [11, 12] , some others could not show such positive findings [13] . The observed discrepancies could be attributed to several reasons including differences in the type of observational or interventional studies, difference in the definitive criteria of postoperative acute kidney injury, the type of employed statistical models and also considering or not considering baseline variables as confounding factors.
As we have shown, using preoperative statins with different doses could not reduce postoperative renal injury even after adjusting potential confounders. Our insignificant results can be explained as follows. Firstly, it can be due to the decreasing effects of cardiopulmonary bypass on serum level of the drug because of its haemodilution effect. In fact, the beneficial renoprotective effects of statins may be shown by administering higher doses of the drug [14] , but in this context, the potential side effects of employing higher drug dosages should be considered. Furthermore, the employed on-pump surgery may be also responsible for lowering the serum level of statins leading to neutralizing its effect on renal function parameters. However, our results support the findings of some previous studies regarding the lack of effects of statins in preventing kidney injury. In a study by Huffmyer et al. [15] , lack of association was found between preoperative statin use and acute kidney injury after coronary bypass surgery. Argalious et al. [16] also found that statin therapy was not associated with acute kidney injury and also with the need for postoperative dialysis. Mithani et al. [9] also showed that statin treatment was not associated with postoperative acute kidney injury after propensity and full adjustments. Also, Bolesta et al. [17] could not support the hypothesis that preoperative statin use was associated with a decrease in the incidence of acute kidney injury after cardiac surgery utilizing cardiopulmonary bypass. Our findings are in contrast to other trials that have shown an association between statin therapy and a reduction in acute kidney injury. Billings et al. [1] found that early postoperative statin use was associated with a lower incidence of acute kidney injury among both chronic statin users and statin-naive cardiac surgery patients. In their study in fact statin withdrawal was associated with a higher incidence of this complication, whereas early postoperative statin use was protective. In total, it seems that the therapeutic interventions with statins preoperatively may have limited effect on the outcome of acute kidney injury even by using high dosages of these drugs.
A review of the literature shows the effect of high-dose statins on preventing kidney damage. However, little data are available about the effects of different dosages of statins especially the new generations of these drugs on kidney function, which can be a strong point of our study. In this regard, the duration of drug administration is a potential variable resulting in different outcomes in previous studies. Having considered this fact, some recent meta-analyses indicated a beneficial effect of recently introduced statins prior to contrast administration in statin-naive patients with suspected coronary involvement who were due to undergo coronary angiography [18] . In contrast, high-quality meta-analyses could not support a major role for statins in reducing kidney injuries in terms of preventing proteinuria or declining glomerular Hosmer-Lemeshow goodness of fit: χ 2 = 9.816, P = 0.278. MI: myocardial infarction; NYHA: New York Heart Association; ACE: angiotensin converting enzyme; LVEF: left ventricular ejection fraction; CI: cardiac index. filtration rate [19] . Along with the studies which presented evidence on the lack of beneficial effects of statins and considering the different doses of administered statins, we could confirm no effects of both high-dose and low-dose statin regimens on reservation of renal function. However, larger trials should be undertaken to examine the beneficial effects and also the safety and efficacy of statins with different dosages in renal protection after cardiac surgeries in high-risk population. Along with discussing beneficial effects of statins on renoprotection, deleterious effects of high-dose statins on kidney function have been also mentioned. An observational study on data of 149 882 patient-years of follow-up failed to demonstrate any increase in renal-related serious events after administering high-dose statins compared with low-dose statins used [20] . Besides, some other studies showed an association between drug dosage, low drug potency and its serious side effects so high-dose and high-potency statins were accompanied with 34% higher adjusted risk of acute kidney injury over the first 4 months of high-dose statin treatment [21] . However, in their studies, it has been also suggested that the use of high-potency statins in those with chronic kidney disorders may not increase the risk of acute kidney injury regardless of the present status of kidney. In total, it can be recommended optimizing statin doses to derive drug benefits and to minimize its side effects.
One of the interesting results in our study was that despite the lower frequency of recent myocardial infarction and also more use of ACE inhibitors in the group receiving high-dose statin compared with other groups, the frequency of kidney injury was not different between the three groups. Although it has been well shown that acute myocardial infarction can be associated with the increased risk for kidney damage in further cardiac ischaemic events [22] , the presence of the history of myocardial infarction on acutely occurring kidney injury remains uncertain. Besides, contradictory findings have been achieved regarding the beneficial or deleterious effects of ACE inhibitors. Although these types of drugs can usually improve renal blood flow as well as decrease progressive renal insufficiency in chronic renal disease, administration of these medications can be also associated with the increased risk for functional renal insufficiency that most commonly appeared shortly after initiating ACE inhibitor [23] . In this context, the lack of association between previous cardiac ischaemic events and the use of ACE inhibitors with present acute kidney injury in our statin groups can be explainable.
In our multivariate regression model, intubation time was shown to be a predictor for increased risk for kidney defects, although this deleterious effect was weak. In a similar study by Heringlake et al. [24] , similar multivariate logistic regression analysis revealed that the time to the first extubation was independently associated with acute kidney injury with an odds ratio of 1.024. Furthermore, the associations between cardiopulmonary bypass time or crossclamping time and postoperative kidney injury have been pointed in some reports. In a study by Khilji et al. [25] , both cardiopulmonary and total cross-clamp times have been known as potential risk factors for developing kidney injury. It seems that ventilation especially with high tidal volumes is associated with postoperative kidney dysfunction after cardiac interventions; however, the power of this association may be affected by the time and duration of intubation or respiratory support. We read the article by Nemati et al. [1] . In this study, they aimed to assess the effects of preoperative administration of statins on lowering the incidence of postoperative acute kidney injury in patients undergoing cardiac surgeries. We congratulate the authors on the study. However there are some contradictory points when compared with literature.
In the literature, there is no consensus about the duration of perioperative statin treatment. Some studies have shown the beneficial pleiotropic statin effects in patients treated with a statin for longer than 1 week before cardiac surgery [2] . The current study lacks detailed information on the duration of perioperative statin treatment. There should also have been a subgroup analysis for the patients for the correlation between duration of the statin usage and the postoperative acute renal failure besides statin dosage. In the study, the patients were categorized into one of the three groups: no statin, low-dose statin or high-dose statin. However, the authors do not present any information on their institutional criterion regarding the start of the statin regimen. If this was in line with guidelines, there should be certain cut-off levels. Current guidelines of the ACC/AHA and NCEP recommend a statin therapy for patients with coronary artery disease (CAD), when serum LDL levels are higher than 100 mg/dl [3] . If these values are also correlated with the extension of the atherosclerosis, there should be also some occult lesions in other vascular sites such as renal arteries, carotid arteries etc. These situations have a direct effect on postoperative outcomes. However, the authors do not present any information on these possible comorbidities. Also for the patient undergoing heart valve surgery, what were the criteria for starting statin therapy?
In the literature, cardiopulmonary and total cross-clamp times and high tidal volumes after cardiac interventions have been known to be potential risk factors for developing kidney injury [4] . However, in the study, there is not enough information on intra-postoperative data for such contributing factors.
The authors stated that they included 1064 consecutive patients into the study. We have some doubts regarding the homogenous nature of the study as it is considered a retrospective study. This high homogeneity of the study brings a possible selection bias to mind. Since authors also do not recommend any patient with missing data in a retrospective study, this situation also brings another question to mind regarding the prospectively designed but retrospectively written nature of the study.
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